<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32293397</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2662-7671</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>23</Day></PubDate></JournalIssue><Title>BMC complementary medicine and therapies</Title><ISOAbbreviation>BMC Complement Med Ther</ISOAbbreviation></Journal><ArticleTitle>Antiviral activity of silymarin in comparison with baicalein against EV-A71.</ArticleTitle><Pagination><StartPage>97</StartPage><MedlinePgn>97</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">97</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12906-020-2880-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hand, foot and mouth disease (HFMD) is a febrile and exanthematous childhood disease mainly caused by Enterovirus 71 (EV-A71). In severe HFMD, virulent EV-A71 strains can cause acute flaccid paralysis and cardiopulmonary edema leading to death. Currently, no FDA approved antiviral treatment or vaccine is available for EV-A71. Flavonoids such as silymarin and baicalein are known to possess in vitro antiviral properties against viruses. In this study, the cytotoxicity and antiviral activity of silymarin, baicalein and baicalin were investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The cytotoxic effects of three flavonoids towards rhabdomyosarcoma (RD) cells were first examined using cell proliferation MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay. Compounds found to be non-cytotoxic in RD cells were evaluated for their in vitro antiviral properties against the EV-A71 subgenotype B4 strain 41 (5865/SIN/000009) using antiviral assays. Viral infectivity was determined by reduction of the formation of plaques in RD cells. For the measurement of RNA copy number, the real time quantitative reverse transcription PCR (qRT-PCR) was used. The most potent compound was further evaluated to determine the mode of action of inhibition by time course, virus attachment and entry assays in Vero cells.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Silymarin was shown to exert direct extracellular virucidal effects against EV-A71 at 50% inhibitory concentration (IC<sub>50</sub>) of 15.2&#x2009;&#xb1;&#x2009;3.53&#x2009;&#x3bc;g/mL with SI of 10.53. Similarly, baicalein exhibited direct extracellular virucidal effects against EV-A71 at a higher IC<sub>50</sub> value of 30.88&#x2009;&#xb1;&#x2009;5.50&#x2009;&#x3bc;g/mL with SI of 13.64. Besides virucidal activity, silymarin was shown to block both viral attachment and entry of EV-A71 to inhibit infection in Vero cells.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Silymarin has a stronger inhibition activity against EV-A71 in comparison to baicalein. It could serve as a promising antiviral&#xa0;drug to treat EV-A71 infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lalani</LastName><ForeName>Salima S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, 47500, Subang Jaya, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anasir</LastName><ForeName>Mohd Ishtiaq</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, 47500, Subang Jaya, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poh</LastName><ForeName>Chit Laa</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-8475-6291</Identifier><AffiliationInfo><Affiliation>Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, 47500, Subang Jaya, Selangor, Malaysia. pohcl@sunway.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>INT-2019-SST-CVVR-01</GrantID><Agency>Sunway University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Complement Med Ther</MedlineTA><NlmUniqueID>101761232</NlmUniqueID><ISSNLinking>2662-7671</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044950">Flavanones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005419">Flavonoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012838">Silymarin</NameOfSubstance></Chemical><Chemical><RegistryNumber>347Q89U4M5</RegistryNumber><NameOfSubstance UI="C038044">baicalin</NameOfSubstance></Chemical><Chemical><RegistryNumber>49QAH60606</RegistryNumber><NameOfSubstance UI="C006680">baicalein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044950" MajorTopicYN="N">Flavanones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005419" MajorTopicYN="N">Flavonoids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012838" MajorTopicYN="N">Silymarin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antivirals</Keyword><Keyword MajorTopicYN="N">Attachment inhibitor</Keyword><Keyword MajorTopicYN="N">Baicalein</Keyword><Keyword MajorTopicYN="N">Enterovirus-71 (EV-A71)</Keyword><Keyword MajorTopicYN="N">Flavonoids</Keyword><Keyword MajorTopicYN="N">Foot and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">Hand</Keyword><Keyword MajorTopicYN="N">Silymarin</Keyword><Keyword MajorTopicYN="N">Virucidal</Keyword></KeywordList><CoiStatement>The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32293397</ArticleId><ArticleId IdType="pmc">PMC7092479</ArticleId><ArticleId IdType="doi">10.1186/s12906-020-2880-2</ArticleId><ArticleId IdType="pii">10.1186/s12906-020-2880-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129(3):304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji T, Han T, Tan X, Zhu S, Yan D, Yang Q, Song Y, Cui A, Zhang Y, Mao N, et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosafety Health. 2019;1:32&#x2013;40. doi: 10.1016/j.bsheal.2019.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2019.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SL, Pan H, Liu P, Amer S, Chan TC, Zhan J, Huo X, Liu Y, Teng Z, Wang L. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol. 2015;25:115&#x2013;128. doi: 10.1002/rmv.1827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1827</ArticleId><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Wang H, Lu Y, Li Q, Chen C, Wang D, Li M, Li Y, Lu J, Chen Z, et al. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China. Vaccine. 2018;36(26):3772&#x2013;3778. doi: 10.1016/j.vaccine.2018.05.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.05.054</ArticleId><ArticleId IdType="pubmed">29776754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang J, Wang L, Ma S, Liu Y. Anti-enterovirus 71 agents of natural products. Molecules. 2015;20(9):16320&#x2013;16333. doi: 10.3390/molecules200916320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules200916320</ArticleId><ArticleId IdType="pmc">PMC6331931</ArticleId><ArticleId IdType="pubmed">26370955</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam E, Teoh BT, Sam SS, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep. 2014;4:5452. doi: 10.1038/srep05452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep05452</ArticleId><ArticleId IdType="pmc">PMC4071309</ArticleId><ArticleId IdType="pubmed">24965553</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res. 2007;51(1):116&#x2013;134. doi: 10.1002/mnfr.200600173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200600173</ArticleId><ArticleId IdType="pmc">PMC7168386</ArticleId><ArticleId IdType="pubmed">17195249</ArticleId></ArticleIdList></Reference><Reference><Citation>Min N, Leong PT, Lee RCH, Khuan JSE, Chu JJH. A flavonoid compound library screen revealed potent antiviral activity of plant-derived flavonoids on human enterovirus A71 replication. Antivir Res. 2018;150:60&#x2013;68. doi: 10.1016/j.antiviral.2017.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.12.003</ArticleId><ArticleId IdType="pubmed">29233744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lani R, Hassandarvish P, Chiam CW, Moghaddam E, Chu JJH, Rausalu K, Merits A, Higgs S, Vanlandingham D, Bakar SA. Antiviral activity of silymarin against chikungunya virus. Sci Rep. 2015;5:11421. doi: 10.1038/srep11421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11421</ArticleId><ArticleId IdType="pmc">PMC4468427</ArticleId><ArticleId IdType="pubmed">26078201</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyak SJ, Oberlies NH, P&#xe9;cheur E-I, Dahari H, Ferenci P, Pawlotsky J-M. Silymarin for hepatitis C virus infection. Antivir Ther. 2013;18(2):141. doi: 10.3851/IMP2402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2402</ArticleId><ArticleId IdType="pmc">PMC4076489</ArticleId><ArticleId IdType="pubmed">23011959</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyak SJ, Morishima C, Lohmann V, Pal S, Lee DY, Liu Y, Graf TN, Oberlies NH. Identification of hepatoprotective flavonolignans from silymarin. Proc Natl Acad Sci U S A. 2010;107:5995&#x2013;5999. doi: 10.1073/pnas.0914009107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914009107</ArticleId><ArticleId IdType="pmc">PMC2851903</ArticleId><ArticleId IdType="pubmed">20231449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferenci P, Dragosics B, Dittrich H, Frank H, Benda L, Lochs H, Meryn S, Base W, Schneider B. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989;9(1):105&#x2013;113. doi: 10.1016/0168-8278(89)90083-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8278(89)90083-4</ArticleId><ArticleId IdType="pubmed">2671116</ArticleId></ArticleIdList></Reference><Reference><Citation>D-e S, Liu L-T, Lin C-C. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res. 2000;20(5A):2861&#x2013;2865.</Citation><ArticleIdList><ArticleId IdType="pubmed">11062694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C-C, Shieh D-E. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med. 1996;24(01):31&#x2013;36. doi: 10.1142/S0192415X96000050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X96000050</ArticleId><ArticleId IdType="pubmed">8739179</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Y, Wu T, Jin Y, Cheng J, Wan C, Qian W, Xing F, Shi W. The antiviral effect of baicalin on enterovirus 71 in vitro. Viruses. 2015;7(8):4756&#x2013;4771. doi: 10.3390/v7082841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082841</ArticleId><ArticleId IdType="pmc">PMC4576202</ArticleId><ArticleId IdType="pubmed">26295407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K, Lim T-H, Rahim N-A, Shu M-H, Teoh B-T, Sam S-S, Danlami M-B, Tan K-K, Abubakar S. Extract of Scutellaria baicalensis inhibits dengue virus replication. BMC Complement Altern Med. 2013;13(1):91. doi: 10.1186/1472-6882-13-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6882-13-91</ArticleId><ArticleId IdType="pmc">PMC3655864</ArticleId><ArticleId IdType="pubmed">23627436</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K, Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem. 1990;108(4):609&#x2013;613. doi: 10.1093/oxfordjournals.jbchem.a123251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.jbchem.a123251</ArticleId><ArticleId IdType="pubmed">2292590</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelis M, Sithisarn P, Cinatl J., Jr Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin a. BMC Res Notes. 2014;7(1):384. doi: 10.1186/1756-0500-7-384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-7-384</ArticleId><ArticleId IdType="pmc">PMC4080993</ArticleId><ArticleId IdType="pubmed">24958200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Chan YF, Sim KM, Tan EL, Poh CL. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS One. 2012;7(5):e34589. doi: 10.1371/journal.pone.0034589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee PTI, Tan KO, Othman I, Poh CL. Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71. J Virol. 2016;13(1):194. doi: 10.1186/s12985-016-0645-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0645-9</ArticleId><ArticleId IdType="pmc">PMC5126835</ArticleId><ArticleId IdType="pubmed">27894305</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen MH, Huang CI, Lee MS, Cheng YP, Hsieh CJ, Chiang LC, Chang JS. Artemisia capillaris inhibited enterovirus 71-induced cell injury by preventing viral internalization. Kaohsiung J Med Sci. 2018;34(3):150&#x2013;159. doi: 10.1016/j.kjms.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kjms.2017.11.005</ArticleId><ArticleId IdType="pubmed">29475462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 2005;43(12):6171&#x2013;6175. doi: 10.1128/JCM.43.12.6171-6175.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.12.6171-6175.2005</ArticleId><ArticleId IdType="pmc">PMC1317214</ArticleId><ArticleId IdType="pubmed">16333123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CW, Leu YL, Horng JT. Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry. Viruses. 2012;4(4):539&#x2013;556. doi: 10.3390/v4040539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4040539</ArticleId><ArticleId IdType="pmc">PMC3347322</ArticleId><ArticleId IdType="pubmed">22590685</ArticleId></ArticleIdList></Reference><Reference><Citation>Camini FC, da Silva TF, da Silva Caetano CC, Almeida LT, Ferraz AC, Vitoreti VMA, de Mello SB, de Queiroz SS, de Magalh&#xe3;es JC, de Brito Magalh&#xe3;es CL. Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress. Antivir Res. 2018;158:8&#x2013;12. doi: 10.1016/j.antiviral.2018.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.07.023</ArticleId><ArticleId IdType="pubmed">30076863</ArticleId></ArticleIdList></Reference><Reference><Citation>Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus. Int J Mol Sci. 2012;13(12):16785&#x2013;16795. doi: 10.3390/ijms131216785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms131216785</ArticleId><ArticleId IdType="pmc">PMC3546721</ArticleId><ArticleId IdType="pubmed">23222683</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Qiao H, Lv Y, Wang J, Chen X, Hou Y, Tan R, Li E. Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS One. 2014;9(10):e110429. doi: 10.1371/journal.pone.0110429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110429</ArticleId><ArticleId IdType="pmc">PMC4199717</ArticleId><ArticleId IdType="pubmed">25330384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, Owen DM, Grove J, Brimacombe C, McKeating JA. Multiple effects of silymarin on the hepatitis C virus lifecycle. J Hepatol. 2010;51(6):1912&#x2013;1921. doi: 10.1002/hep.23587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.23587</ArticleId><ArticleId IdType="pmc">PMC2909978</ArticleId><ArticleId IdType="pubmed">20512985</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo A, Teoh BT, Sam SS, Bakar SA, Zandi K. Baicalein and baicalin as Zika virus inhibitors. Arch Virol. 2019;164(2):585&#x2013;593. doi: 10.1007/s00705-018-4083-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-018-4083-4</ArticleId><ArticleId IdType="pubmed">30392049</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Liu SC, Huang PN, Chang HY, Chern JH, Shih SR. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J Biomed Sci. 2008;15(3):291&#x2013;300. doi: 10.1007/s11373-007-9228-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-007-9228-5</ArticleId><ArticleId IdType="pubmed">18196474</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Yap ML, Cardosa J, Kuhn RJ, Rossmann MG. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc Natl Acad Sci U S A. 2013;110(14):5463&#x2013;5467. doi: 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu YH, Chan YL, Tsai LW, Li TL, Wu CJ. Prevention of human enterovirus 71 infection by kappa carrageenan. Antivir Res. 2012;95(2):128&#x2013;134. doi: 10.1016/j.antiviral.2012.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.05.009</ArticleId><ArticleId IdType="pubmed">22643729</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimizu H. Cellular receptors for human enterovirus species a. Front Microbiol. 2012;3:105. doi: 10.3389/fmicb.2012.00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00105</ArticleId><ArticleId IdType="pmc">PMC3313065</ArticleId><ArticleId IdType="pubmed">22470371</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Su W, Jin J, Chen J, Li X, Zhang X, Sun M, Sun S, Fan P, An D. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses. 2014;6(7):2778&#x2013;2795. doi: 10.3390/v6072778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6072778</ArticleId><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="pubmed">25036464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>